Companies / ADMA Biologics Inc / Activity
Activity — ADMA Biologics Inc
54 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | Grossman Adam S CEO | Other | Common Stock | $868.6K | -56K -2.56% | 2,148,290 0.96% of shares | low |
| Feb 26, 2026 | Grossman Adam S CEO | Other | Common Stock | $832.7K | -55K -2.43% | 2,204,728 0.98% of shares | low |
| Mar 7, 2026 | Grossman Adam S CEO | Other | Common Stock | $454.2K | -30K -1.37% | 2,118,777 0.95% of shares | low |
| Feb 19, 2026 | Grossman Adam S CEO | Other | Common Stock | $404.6K | -25K -1.09% | 2,259,586 1.01% of shares | low |
| Feb 17, 2026 | Grossman Adam S CEO | Sell | Common Stock | $241.2K | -15K -0.65% | 2,290,379 1.02% of shares | medium |
| Mar 16, 2026 | Grossman Adam S CEO | Sell | Common Stock | $227.4K | -15K -0.70% | 2,118,777 0.95% of shares | medium |
| Apr 1, 2026 | Kestenberg-Messina Kaitlin M. Executive | Other | Common Stock | $185.5K | -20K -4.36% | 446,238 0.20% of shares | low |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Executive | Sell | Common Stock | $157.8K | -10K -2.12% | 466,600 0.21% of shares | medium |
| Mar 6, 2026 | Kestenberg-Messina Kaitlin M. Executive | Other | Common Stock | $154.8K | -10K -1.76% | 562,101 0.25% of shares | low |
| Feb 19, 2026 | Kestenberg-Messina Kaitlin M. Executive | Other | Common Stock | $133.2K | -8K -1.41% | 572,160 0.26% of shares | low |
| Mar 13, 2026 | Guiheen Lawrence P. Director | Exercise | Common Stock | $109.8K | +30K +28.43% | 135,520 0.06% of shares | low |
| Mar 5, 2026 | Elms Steve Director | Buy | Common Stock | $109.7K | +7K +0.34% | 2,038,730 0.91% of shares | medium |
| Mar 6, 2026 | Elms Steve Director | Buy | Common Stock | $107.7K | +7K +0.34% | 2,045,730 0.91% of shares | medium |
| Feb 19, 2026 | Tade Brad L. Executive | Other | Common Stock | $105.7K | -6K -2.71% | 232,940 0.10% of shares | low |
| May 12, 2026 | Grossman Jerrold B Director | Buy | Common Stock | $100.1K | +13K +2.49% | 513,884 0.23% of shares | medium |
| May 11, 2026 | Grossman Jerrold B Director | Buy | Common Stock | $100.1K | +13K +2.56% | 501,384 0.22% of shares | medium |
| Feb 17, 2026 | Grossman Adam S CEO | Sell | Common Stock | $96.5K | -6K -0.26% | 2,284,379 1.02% of shares | low |
| Mar 16, 2026 | Grossman Adam S CEO | Sell | Common Stock | $91.0K | -6K -0.28% | 2,112,777 0.94% of shares | low |
| Mar 16, 2026 | Grossman Adam S CEO | Exercise | Common Stock | $81.0K | +15K +0.71% | 2,133,777 0.95% of shares | low |
| Feb 17, 2026 | Grossman Adam S CEO | Exercise | Common Stock | $81.0K | +15K +0.65% | 2,305,379 1.03% of shares | low |
| Mar 7, 2026 | Kestenberg-Messina Kaitlin M. Executive | Other | Common Stock | $65.2K | -4K -0.75% | 557,866 0.25% of shares | low |
| May 27, 2026 | Grossman Jerrold B Director | Buy | Common Stock | $50.6K | +6K +1.25% | 520,284 0.23% of shares | low |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Executive | Exercise | Common Stock | $12.5K | +3K +0.54% | 469,100 0.21% of shares | low |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Executive | Exercise | Common Stock | $7.5K | +3K +0.56% | 472,996 0.21% of shares | low |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Executive | Exercise | Common Stock | $5.4K | +1K +0.27% | 470,350 0.21% of shares | low |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Executive | Exercise | Common Stock | $3.6K | +2K +0.32% | 474,521 0.21% of shares | low |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Executive | Exercise | Common Stock | $3.4K | +2K +0.46% | 476,696 0.21% of shares | low |
| Feb 9, 2026 | Kwon Young Director | Grant | Common Stock | $0 | +11K +4.24% | 263,020 0.12% of shares | low |
| Feb 9, 2026 | Finger Alison Cecily Director | Grant | Common Stock | $0 | +11K +30.60% | 45,619 0.02% of shares | low |
| Mar 17, 2026 | Guiheen Lawrence P. Director | Gift | Common Stock | $0 | +30K | 30,000 0.01% of shares | low |
| Mar 17, 2026 | Guiheen Lawrence P. Director | Gift | Common Stock | $0 | -30K -22.14% | 105,520 0.05% of shares | low |
| Feb 9, 2026 | Guiheen Lawrence P. Director | Grant | Common Stock | $0 | +11K +11.27% | 105,520 0.05% of shares | low |
| Feb 9, 2026 | Grossman Jerrold B Director | Grant | Common Stock | $0 | +11K +2.24% | 488,884 0.22% of shares | low |
| Feb 9, 2026 | Grossman Adam S CEO | Grant | Common Stock | $0 | +283K +14.07% | 2,290,379 1.02% of shares | low |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Executive | Other | Common Stock | $0 | -91K -16.36% | 466,600 0.21% of shares | low |
| Feb 9, 2026 | Kestenberg-Messina Kaitlin M. Executive | Grant | Common Stock | $0 | +92K +18.75% | 580,321 0.26% of shares | low |
| Feb 9, 2026 | Salas Eduardo Rene Director | Grant | Common Stock | $0 | +11K +98.17% | 21,579 <0.01% of shares | low |
| Feb 9, 2026 | Elms Steve Director | Grant | Common Stock | $0 | +11K +12.24% | 98,020 0.04% of shares | low |
| Feb 9, 2026 | Kwon Young Director | Grant | Stock Option (Right to Buy) | — | +18K | 17,730 <0.01% of shares | low |
| Feb 9, 2026 | Finger Alison Cecily Director | Grant | Stock Option (Right to Buy) | — | +18K | 17,730 <0.01% of shares | low |
| Mar 13, 2026 | Guiheen Lawrence P. Director | Exercise | Stock Option (Right to Buy) | — | -30K -55.72% | 23,837 0.01% of shares | low |
| Feb 9, 2026 | Guiheen Lawrence P. Director | Grant | Stock Option (Right to Buy) | — | +18K | 17,730 <0.01% of shares | low |
| Feb 9, 2026 | Grossman Jerrold B Director | Grant | Stock Option (Right to Buy) | — | +18K | 17,730 <0.01% of shares | low |
| Mar 16, 2026 | Grossman Adam S CEO | Exercise | Stock Option (right to buy) | — | -15K -2.12% | 690,950 0.31% of shares | low |
| Feb 17, 2026 | Grossman Adam S CEO | Exercise | Stock Option (right to buy) | — | -15K -2.08% | 705,950 0.32% of shares | low |
| Feb 9, 2026 | Grossman Adam S CEO | Grant | Stock Option (right to buy) | — | +445K | 444,711 0.20% of shares | low |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Executive | Exercise | Stock Option (right to buy) | — | -2K -43.50% | 2,825 <0.01% of shares | low |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Executive | Exercise | Stock Option (right to buy) | — | -2K -40.67% | 2,225 <0.01% of shares | low |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Executive | Exercise | Stock Option (right to buy) | — | -3K -48.85% | 2,771 <0.01% of shares | low |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Executive | Exercise | Stock Option (right to buy) | — | -1K -50.00% | 1,250 <0.01% of shares | low |